News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
98
Sources here
16
Companies here
11
Search results Stored financial headlines

Active search

98 matching headlines

Ticker or company: COSMMain company stories
Clear
Latest

Stock Titan Earnings

Cosmos Health Inc. SEC Filing (Aug 14, 2026)

Cosmos Health Inc. (COSM) has filed a Form 12b-25 Notification of Late Filing, indicating that it will not be able to file its Quarterly Report on Form 10-Q for the period ended June 30, 2026, on time. The delay is attributed to difficulties in compiling necessary information, including the XBRL filing, which the company states could not be …

Cosmos Health Inc expected to post earnings of 1 cent a share - Earnings Preview

Cosmos Health Inc is anticipated to report earnings of 1 cent per share. This article provides an earnings preview for the company. Access to the full Reuters article is available through a TradingView subscription.

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Price to earnings forward of Cosmos Health Inc – DUS:V67A

This article provides financial data for Cosmos Health Inc (DUS:V67A) on the Dusseldorf Stock Exchange, specifically focusing on its forward price-to-earnings ratio. It presents a data table with period values and changes, noting that the market is currently closed with no trades. The content …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cosmos Health Inc (COSM), noting that no earnings forecast score is currently available, but the Pharmaceuticals industry average is 7.86. Analysts have set an average price target of $3.00 for COSM, representing a significant upside. Key financial …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmo First Ltd Share: வருவாய் **46%** உயர்வு! முதலீட்டாளர்களுக்கு காத்திருக்கும் லாபம்!

COSMOFIRST main company
Sharemaestro market context Trend signal active 52 weeks -8.0% · Next-week setup negative 42.0% COSMOFIRST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health (NASDAQ: COSM) CEO swaps $70K debt for 349,825 shares

Grigorios Siokas, CEO and Director of Cosmos Health Inc. (NASDAQ: COSM), acquired 349,825 shares of common stock at $0.2001 per share through a debt exchange agreement on July 30, 2026. This transaction converted $70,000 of debt owed to him by the company into equity. …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 4 Cosmos Health Inc. For: 30 July By Investing.com

This article reports on a Form 4 filing for Cosmos Health Inc. (COSM) related to July 30th activities. It indicates that the company's stock experienced a 7.75% increase. The content primarily serves as a brief announcement for the financial filing.

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock

Cosmos Health Inc. CFO Georgios Terzis acquired 328,407 shares of company common stock at $0.1827 per share. These shares were issued as part of a debt-for-equity exchange totaling $60,000, settling a debt the company owed to Mr. Terzis. Following this transaction, his direct holdings …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Advances Its Technology-Driven Transformation

Cosmos Health Inc. is developing an AI-enabled subscription platform for its consumer health products, marking a significant step in its technology-driven transformation. The platform will cater to both B2C and B2B channels, offering personalized recommendations based on customer health goals and supporting employee wellness …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NOOR Collagen Repeat Rate Above 60% as Cosmos Health Develops AI Platform

Cosmos Health is actively developing an AI-enabled digital subscription platform for its consumer health products, targeting both B2C and B2B channels. The initiative builds on the success of its U.S. NOOR Collagen subscription model, which boasts an early repeat purchase rate of over 60%. …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cosmos Health Inc (COSM), focusing on its support and resistance levels, various technical indicators, and moving averages. The stock is currently trading within a range, with a price momentum score of 6.11. The analysis provides signals from …

COSM main company
Sharemaestro market context Price below Trend Line 52 weeks -74.1% · Next-week setup negative 39.4% COSM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context